1Cell.Ai

Revolutionizing Next-Gen Translational Research

[1Cell.Ai @1cellAi]

AI is reshaping oncology drug development, not just how we discover targets, but how we match them to patients.

We’re building tools that help oncologists and trial teams make faster, smarter decisions using single cell multi-omics and AI.

https://t.co/v1pExxy7f9
#CancerCare

[Celesta Capital @CelestaCapital]

Digital pathology 2.0 = a cost reset for cancer care. @1cellAi uses AI on biopsy slides to make pathology a fast, low-cost front door to NGS—cutting $4–5K tests by orders of magnitude and expanding access to 1M+ patients. Full convo with founder @MohanUttarwar 👇

[1Cell.Ai @1cellAi]

Lung cancer demands earlier detection + smarter monitoring.

At #WCLC2025, our team will share how 1Cell’s AI-powered single cell platform delivers high-res, multi-omic insights from a simple blood draw—supporting precision at every stage of care.

[David Joshua Ferguson @djferguson242]

🚀 Coming This August on Lecture-casts from The New Chemist's Podcasting Group: 🚀

Join Mohan Uttarwar, CEO & Co-Founder of https://t.co/MJ5tmxDw0d, as he reveals how AI-powered single-cell analytics in the OncoIncytes platform are transforming precision oncology—from real-time tumor profiling (ctDNA, CTCs, scRNA & proteomics) and smarter ADC trials to emerging therapy trends and scaling a global biotech.
🎧 Subscribe now to be first to hear actionable insights on AI in drug development and advice for aspiring founders

#LectureCasts #ComingSoon #PrecisionOncology #ChemistryPodcast #Biotech #AIinHealthcare #DrugDevelopment

[1Cell.Ai @1cellAi]

On The Making of KOLs podcast, https://t.co/bmyeZPjVE8 CEO Mohan Uttarwar shares how our OncoIncytes platform combines ctDNA, live CTCs, single cell RNA & proteomics to give doctors real-time tumor insights.

The future of cancer care is here. 🎧
https://t.co/gkhV3tthEK

[1Cell.Ai @1cellAi]

AI is helping clinicians catch and treat lung cancer earlier and with more precision.

At https://t.co/bmyeZPjVE8, our single cell platform turns blood-based data into actionable insights to guide care at every stage.

https://t.co/8TdEsSZA8V

[1Cell.Ai @1cellAi]

We're headed to #WCLC2025 in Barcelona!

Visit 1Cell at Booth 421 to explore how our AI-powered single cell platform is advancing multi-omic insight from a blood draw.

Sept 6–9 | 📍 Barcelona

More: https://t.co/hDXVNWbUD1
#LungCancer #PrecisionOncology #1CellAi

[OncoDaily @oncodaily]

Secure Your Spot for the IASLC World Conference on Lung Cancer (WCLC 2025)
@IASLC

https://t.co/YxZToEqMdh

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #WCLC25

[1Cell.Ai @1cellAi]

"AI in oncology can't succeed in silos."

J&J's Biljana Naumovic calls for shared data & collaboration across healthcare to scale impact - something we’re building every day at https://t.co/bmyeZPjVE8 with AI-ready, harmonized single cell data.

https://t.co/Z229z3yYDX
#AI

[1Cell.Ai @1cellAi]

AI is transforming cancer care - diagnosis, treatment, and trials.
🔹 44% ↓ radiologist workload
🔹 96% accuracy in pathology
🔹 Smarter trial matching + streamlined workflows

A powerful future is unfolding.

https://t.co/BvISyE4TRb

[1Cell.Ai @1cellAi]

“Good data beats more data every day.”

City of Hope’s Nasim Eftekhari shares how AI is reshaping cancer care - with a strong focus on trust, data integrity & people-powered strategy.
https://t.co/TYLIG2igIo

#AI #Oncology #DataScience

[1Cell.Ai @1cellAi]

https://t.co/bmyeZPjVE8 was featured in @BioSpace for its role in solving a major AI challenge in oncology: data harmonization.
The iCore platform unifies diverse datasets to power more reliable AI.

Read more: https://t.co/ODxaWxYttg
#1CellAi #PrecisionOncology #AI #iCore

[1Cell.Ai @1cellAi]

New AI-driven blood test detects brain tumors in 73% of cases, up from <10% with older methods.
We’re developing AI + multi-omics platforms to support long-term cancer care.

https://t.co/LfqflntFDr
#1CellAi #CancerCare #AI

[1Cell.Ai @1cellAi]

Predictive genomics is transforming breast cancer care - from risk reduction to personalized treatment.

At @1cellAi, we’re advancing multi-omic tools to help power this shift and bring more precision to every patient journey.

https://t.co/00DhMLewSZ

[1Cell.Ai @1cellAi]

New study from @UCLAHealth links cardiac biomarkers to future cancer risk, even in patients without heart disease. It’s a powerful reminder: Cancer care must be systemic, not siloed.

https://t.co/R74Frc2Qdn
#1CellAi #CancerCare #Biomarkers #CardioOncology #MultiOmics

[1Cell.Ai @1cellAi]

CAR T-cell therapy once used only in cancer may offer long-term remission for patients with severe lupus. This cross-disciplinary success shows how oncology innovations are shaping the next era of personalized care. Read more https://t.co/qiUQ4PtNAW
#CancerCare #PrecisionMedicine

[1Cell.Ai @1cellAi]

VCU’s new TACIT algorithm cuts cell ID time from weeks to minutes - a win for long-term cancer care.

We believe AI + multi-omics is key to advancing trial design, treatment decisions & real-world care strategies.

https://t.co/OfvGpKdYWj
#1CellAi #CancerCare #AI #MultiOmics

[1Cell.Ai @1cellAi]

“Cancer is a deeply individualized disease.”
Our CEO Mohan Uttarwar joins leaders across biotech in this @BioSpace feature exploring how AI is transforming diagnostics, drug development, and multi-omics in oncology.

Read more: https://t.co/59FxeOL1F0
#PrecisionOncology #AI

[1Cell.Ai @1cellAi]

Colorectal cancer is hitting younger adults harder and biomarker testing is key to earlier, smarter treatment.

At https://t.co/bmyeZPjVE8, we’re building ctDNA + single cell tools to help detect and manage CRC with precision.

Learn more: https://t.co/I40PVqAs29

#1CellAi

[1Cell.Ai @1cellAi]

A new study shows AI can flag mammogram patterns 4–6 years before breast cancer diagnosis.

As precision tools advance, so does early risk detection. At https://t.co/bmyeZPjVE8, we're building AI + single cell platforms for earlier, smarter cancer care.

https://t.co/YAgD31Oaab